[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy",
    "summary": "Vertex Pharmaceuticals (NasdaqGS:VRTX) saw its share price rise by approximately 14% in the last quarter, a significant move considering the broader market's recent 1% decline. The company's legal challenges, such as the patent infringement lawsuit filed by ToolGen Inc., could have influenced investor sentiment, highlighting the competitive tensions in the biotech sector. Furthermore, the recent European label expansion for KAFTRIO and advancements in its Type 1 diabetes portfolio may have...",
    "url": "https://finnhub.io/api/news?id=9776d9c498d2595447742c02fcf08bd51ebfe1e637d39fecee9fb48dadefabd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745255754,
      "headline": "Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy",
      "id": 134026446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (NasdaqGS:VRTX) saw its share price rise by approximately 14% in the last quarter, a significant move considering the broader market's recent 1% decline. The company's legal challenges, such as the patent infringement lawsuit filed by ToolGen Inc., could have influenced investor sentiment, highlighting the competitive tensions in the biotech sector. Furthermore, the recent European label expansion for KAFTRIO and advancements in its Type 1 diabetes portfolio may have...",
      "url": "https://finnhub.io/api/news?id=9776d9c498d2595447742c02fcf08bd51ebfe1e637d39fecee9fb48dadefabd9"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b92a98041f84e70ef7ce9224a7f8aa7efb5162eb5ecae557c456b6722668d65c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745253360,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
      "id": 134055395,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b92a98041f84e70ef7ce9224a7f8aa7efb5162eb5ecae557c456b6722668d65c"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Say 12 Stocks Will Profit Most From Trump's Reign",
    "summary": "Analysts Say 12 Stocks Will Profit Most From Trump's Reign",
    "url": "https://finnhub.io/api/news?id=9a8e29d1df8805185b1a1a261cf968831193f7855a624ea7246591aceb6574f0",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745222456,
      "headline": "Analysts Say 12 Stocks Will Profit Most From Trump's Reign",
      "id": 134053893,
      "image": "",
      "related": "VRTX",
      "source": "DowJones",
      "summary": "Analysts Say 12 Stocks Will Profit Most From Trump's Reign",
      "url": "https://finnhub.io/api/news?id=9a8e29d1df8805185b1a1a261cf968831193f7855a624ea7246591aceb6574f0"
    }
  },
  {
    "ts": null,
    "headline": "uniQure: Huntington's Gene Therapy Advances, But Commercial Hurdles Keep This A Hold",
    "summary": "uniQure: Huntington's Gene Therapy Advances, But Commercial Hurdles Keep This A Hold",
    "url": "https://finnhub.io/api/news?id=1eeb30b01d0862d45806f1f8f234cc68897276a1690ff53a8952788e77f627ea",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745220600,
      "headline": "uniQure: Huntington's Gene Therapy Advances, But Commercial Hurdles Keep This A Hold",
      "id": 134021342,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=1eeb30b01d0862d45806f1f8f234cc68897276a1690ff53a8952788e77f627ea"
    }
  }
]